IRIS - Res&Arch Institutional Research Information System - Research & Archive

RIUZZI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.463
AS - Asia 3.458
EU - Europa 3.035
SA - Sud America 648
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 74
OC - Oceania 5
Totale 11.946
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.354
SG - Singapore 1.516
IT - Italia 641
BR - Brasile 525
HK - Hong Kong 525
CN - Cina 473
UA - Ucraina 472
IE - Irlanda 443
RU - Federazione Russa 353
VN - Vietnam 271
KR - Corea 197
DE - Germania 195
SE - Svezia 179
FR - Francia 158
FI - Finlandia 137
GB - Regno Unito 119
IN - India 84
BD - Bangladesh 73
NL - Olanda 66
CA - Canada 56
RO - Romania 56
TR - Turchia 52
AT - Austria 44
IQ - Iraq 43
AR - Argentina 42
JP - Giappone 33
PL - Polonia 31
ES - Italia 28
PH - Filippine 28
CO - Colombia 25
CH - Svizzera 23
PK - Pakistan 23
MX - Messico 21
BE - Belgio 20
ZA - Sudafrica 20
CZ - Repubblica Ceca 18
EC - Ecuador 18
ID - Indonesia 18
UZ - Uzbekistan 16
MY - Malesia 14
SA - Arabia Saudita 14
VE - Venezuela 13
CL - Cile 11
LB - Libano 11
EG - Egitto 10
MA - Marocco 10
JM - Giamaica 9
TN - Tunisia 9
IR - Iran 7
MD - Moldavia 7
PY - Paraguay 7
GR - Grecia 6
LT - Lituania 6
PE - Perù 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BG - Bulgaria 5
ET - Etiopia 5
IL - Israele 5
JO - Giordania 5
KH - Cambogia 5
NI - Nicaragua 5
TH - Thailandia 5
BA - Bosnia-Erzegovina 4
KG - Kirghizistan 4
OM - Oman 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EU - Europa 3
HU - Ungheria 3
KE - Kenya 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AU - Australia 2
BY - Bielorussia 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LV - Lettonia 2
MU - Mauritius 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
Totale 11.666
Salva come PNG Salva come JPEG
Città #
Singapore 1.190
Chandler 544
Hong Kong 512
Dublin 438
San Jose 355
Ashburn 279
Jacksonville 257
San Mateo 228
Boardman 178
Santa Clara 175
Perugia 170
Moscow 130
Seoul 127
Lauterbourg 108
Medford 107
Wilmington 107
Princeton 106
The Dalles 103
Beijing 100
Dong Ket 94
Ann Arbor 89
Altamura 75
Los Angeles 75
New York 63
Andover 59
Ho Chi Minh City 56
Munich 52
Lawrence 49
Piscataway 49
Bucharest 48
Des Moines 46
São Paulo 43
Hanoi 38
Falls Church 33
Dearborn 32
Vienna 31
Shanghai 29
Turin 29
Council Bluffs 28
Helsinki 28
Norwalk 28
Orem 28
Bologna 26
Tokyo 26
Saint Petersburg 25
Redmond 24
Montreal 23
Dallas 22
Rio de Janeiro 20
Boston 19
Brussels 19
Turku 19
Warsaw 19
Amsterdam 18
Chicago 18
Seongnam-si 18
Woodbridge 18
Brooklyn 16
London 16
Stockholm 16
Chennai 15
Falkenstein 15
Frankfurt am Main 15
Houston 15
Phoenix 15
San Francisco 15
Baghdad 13
Denver 13
Izmir 13
Johannesburg 13
Atlanta 12
Da Nang 12
Milan 12
Rome 12
Brasília 11
Nuremberg 11
Olomouc 11
Redwood City 11
Tashkent 11
Dhaka 10
Philadelphia 10
Ankara 9
Cebu City 9
Groningen 9
Manchester 9
Mumbai 9
Parma 9
Columbus 8
Haiphong 8
Incheon 8
Istanbul 8
Toronto 8
Buffalo 7
Cairo 7
Glasgow 7
Guangzhou 7
Lahore 7
Quito 7
Riyadh 7
Seodaemun-gu 7
Totale 7.093
Salva come PNG Salva come JPEG
Nome #
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 283
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 199
An HMGB1/RAGE/p38 MAPK/Myogenin Axis Modulates Pax7 Expression in Myoblasts by Both Transcriptional and Post-Transcriptional Mechanisms 182
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 152
Oxidative stress-induced S100B accumulation converts myoblasts into brown adipocytes via an NF-κB/YY1/miR-133 axis and NF-κB/YY1/BMP-7 axis 151
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 151
RAGE in the pathophysiology of skeletal muscle. 147
Differential expression of S100B protein and RAGE in young and aged human satellite cells. 144
Equisetum arvense standardized extract hinders age-related sarcopenia 140
A braking circuit between pathogen- and danger-sensing signaling pathways restrains lung inflammation: role of S100B protein, RAGE and Toll-like receptors. 140
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 139
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 138
Amphoterin-induced myogenic differentiation of RAGE-transfected rhabdomyosarcoma TE671 cells 137
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 136
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 136
Cellular and molecular mechanisms of sarcopenia: the S100B perspective 135
Activation of RAGE in myoblasts and rhabdomyosarcoma cells results in downregulation of Pax7 expression 134
Natural products to counteract muscle atrophy 133
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 132
RAGE signalling in myoblasts and embryonal rhabdomyosarcoma cells represses Pax7 expression via p38 MAPK-dependent induction of myogenin. 130
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 130
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 130
Screening of 100 plant extracts for the development of a herbal product effective against muscle atrophy 129
Aged vs young human satellite cells: altered expression of S100B and RAGE, and defective ability in conditioning the medium contribute to impaired myogenic potential. 128
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 127
Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control 126
S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond 125
Amphoterin stimulates myogenesis and counteracts the anti-myogenic factors, bFGF and S100B, via RAGE binding 124
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 124
RAGE expression in rhabdomyosarcoma cells results in reduced proliferation, migration, and invasiveness in vitro and tumor growth in vivo 120
Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis 120
Implication of RAGE and Amphoterin in Myogenesis 118
Different intrinsic properties of young and aged human satellite cells. 118
Appropriate levels of extracellular S100B protein in injured muscle are required for correct muscle regeneration. 115
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 112
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 108
Young and Aged Human Muscle Satellite Cells Show Differential Expression of S100B Protein and RAGE. 108
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 107
S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner 107
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 107
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 107
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 107
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 105
RAGE engagement in myoblasts modulates proliferation, apoptosis, adhesiveness, migration and invasiveness 104
S100B protein in tissue development, repair and regeneration 104
RAGE signaling in myoblasts and rhabdomyosarcoma cells causes downregulation of Pax7 expression via p38 MAPK activation and upregulation of myogenin expression 103
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 103
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 103
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 102
The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation 102
Causes of elevated serum levels of S100B protein in athletes 102
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 101
Caveolins and cavins in muscle-derived tumours. 100
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 99
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 99
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 98
Effects of deletion of RAGE in muscle regeneration: preliminary observations. 97
Functions of S100 proteins 97
Complex regulatory effects of extracellular S100B on myoblast differentiation: S100B activates quiescent myoblats and satellite cells 96
S100B protein differentially regulates myoblast differentiation via direct binding to RAGE and bFGF-mediated activation of FGFR1 in low-density and high-density cultures, respectively 95
S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration 95
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 95
Reductive stress in striated muscle cells 95
Human muscle satellite cells show age-related differential expression of S100B protein and RAGE. 94
The receptor RAGE: a potential molecular target in cancer cachexia 94
S100 proteins in obesity: liaisons dangereuses 94
Opposing regulatory roles of S100B and amphoterin in myogenic differentiation: RAGE-dependence of amphoterin stimulatory effects vs. RAGE-independence of S100B inhibitory effects 93
S100B's double life: Intracellular regulator and extracellular signal. 92
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 90
RAGE expression in rhabdomyosarcoma cells modulates metastasis formation in vivo. 90
RAGE-independence of S100B inhibition of myogenic differentiation and myotube formation 90
Functional inactivation of RAGE in myoblasts results in tumor formation 89
Spatiotemporal regulation of Toll-like receptors and RAGE signaling pathways by S100B protein restrains inflammation 89
Elucidating the mechanism of S100B-dependent regulation of myoblast differentiation. 88
Molecular mechanism of S100B-dependent inhibition of myoblast differentiation 88
S100B activates quiescent myoblasts and satellite cells 85
Delayed Muscle Regeneration in RAGE-/- Skeletal Muscles. 84
Mechanism of S100B-dependent inhibition of myoblast differentiation 83
S100B protein in skeletal muscle regeneration: regulation of myoblast and macrophage functions 83
The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo 82
Enforced expression of RAGE in rhabdomyosarcoma cells result in reduced proliferation, migration, and invasiveness in vitro, activation of a myogenic program, and reduced tumor growth in vivo. 82
S100B-dependent inhibition of myoblast differentiation: molecular mechanism 81
Potential role of S100B protein in myogenesis and skeletal muscle regeneration 81
Differential involvement of RAGE and FGFR1 in S100B effects on myoblast differentiation 81
Differential engagement of RAGE and FGFR1 in muscle satellite cells by S100B protein: involvement of RAGE in satellite cell activation and of FGFR1 on satellite cell expansion. 81
Phosphocaveolin-1 Enforces Tumor Growth and Chemoresistance in Rhabdomyosarcoma 81
S100B protein accelerates the activation of quiescent myoblasts and muscle satellite cells. 80
HMGB1/RAGE modulates Pax7 expression in myoblasts via p38 MAPK-dependent upregulation of myogenin. 80
S100B protein restrains inflammation via spatiotemporal regulation of pathogen- and danger-sensing signaling pathways. 79
S100B causes apoptosis in myoblasts and inhibits myogenic differentiation and myotube formation in a RAGE-independent manner 78
S100B inhibits myoblast differentiation via activation of a Ras-MEK-ERK1/2 signaling pathway 78
RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth 77
The many faces of S100B protein: when an extracellular factor inactivates its own receptor and activates another one. 77
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 76
Effects of RAGE expression in rhabdomyosarcoma cells 75
S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner 75
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 74
RAGE modulates myoblast proliferation, apoptosis, migration and invasiveness 74
S100B activates muscle satellite cells via RAGE engagement 74
Re-expression of RAGE in damaged skeletal muscles: RAGE-/- mice show delayed muscle regeneration 74
Totale 10.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022931 0 168 26 43 33 20 16 264 19 44 110 188
2022/20231.620 134 273 28 131 133 184 2 76 571 4 60 24
2023/2024737 43 70 29 31 15 18 211 23 80 16 87 114
2024/20252.294 55 203 165 106 297 109 203 208 358 122 340 128
2025/20264.248 267 220 181 537 548 413 739 233 457 335 235 83
2026/2027236 211 25 0 0 0 0 0 0 0 0 0 0
Totale 11.946